BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34101529)

  • 1. The impact of HPV genotypes on survival in HPV-positive oropharyngeal squamous cell carcinomas: a systematic review.
    Skovvang A; Jensen JS; Garset-Zamani M; Carlander A; Grønhøj C; von Buchwald C
    Acta Otolaryngol; 2021 Jul; 141(7):724-728. PubMed ID: 34101529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.
    Mazul AL; Rodriguez-Ormaza N; Taylor JM; Desai DD; Brennan P; Anantharaman D; Gheit T; Tommasino M; Abedi-Ardekani B; Olshan AF; Zevallos JP
    Oral Oncol; 2016 Oct; 61():98-103. PubMed ID: 27688111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Garset-Zamani M; Carlander AF; Jakobsen KK; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; von Buchwald C
    Int J Cancer; 2022 Apr; 150(7):1174-1183. PubMed ID: 34894151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
    Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.
    Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S
    J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study.
    Lorenzatti Hiles G; Chang KP; Bellile EL; Wang CI; Yen WC; Goudsmit CM; Briggs HL; Thomas TB; Peters L; Afsari MA; Pinatti LM; Morris AC; Jawad N; Carey TE; Walline HM
    PLoS One; 2021; 16(4):e0250530. PubMed ID: 33891627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
    Wang Z; Xia RH; Ye DX; Li J
    PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.
    Rietbergen MM; Martens-de Kemp SR; Bloemena E; Witte BI; Brink A; Baatenburg de Jong RJ; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Eur J Cancer; 2014 Mar; 50(4):765-73. PubMed ID: 24315751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
    Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
    Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
    Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
    Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.
    Amini A; Jasem J; Jones BL; Robin TP; McDermott JD; Bhatia S; Raben D; Jimeno A; Bowles DW; Karam SD
    Oral Oncol; 2016 May; 56():1-7. PubMed ID: 27086480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.
    Sinha P; Karadaghy OA; Doering MM; Tuuli MG; Jackson RS; Haughey BH
    Oral Oncol; 2018 Nov; 86():121-131. PubMed ID: 30409292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma.
    Elhalawani H; Mohamed ASR; Elgohari B; Lin TA; Sikora AG; Lai SY; Abusaif A; Phan J; Morrison WH; Gunn GB; Rosenthal DI; Garden AS; Fuller CD; Sandulache VC
    BMC Cancer; 2020 Sep; 20(1):912. PubMed ID: 32967643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for active human papillomavirus (HPV) in fields surrounding HPV-positive oropharyngeal tumors.
    Rietbergen MM; Braakhuis BJ; Moukhtari N; Bloemena E; Brink A; Sie D; Ylstra B; Baatenburg de Jong RJ; Snijders PJ; Brakenhoff RH; Leemans CR
    J Oral Pathol Med; 2014 Feb; 43(2):137-42. PubMed ID: 24118314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16 increases the number of migratory cancer stem cells and modulates their miRNA expression profile in oropharyngeal cancer.
    Hufbauer M; Maltseva M; Meinrath J; Lechner A; Beutner D; Huebbers CU; Akgül B
    Int J Cancer; 2018 Sep; 143(6):1426-1439. PubMed ID: 29663357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.